U.S. market Closed. Opens in 11 hours 16 minutes

DRTS | Alpha Tau Medical Ltd. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue1.07M979.00K776.00K86.00KN/A
Gross Profit-1.07M-979.00K-776.00K-86.00KN/A
Operating Expenses34.61M32.14M13.79M9.24M8.01M
Selling, General & Admin8.18M11.25M2.34M1.70M1.37M
Research & Development26.42M20.89M11.45M7.54M6.64M
Other Operating ExpensesN/AN/AN/AN/AN/A
Operating Income-35.68M-32.14M-13.79M-9.24M-8.01M
Other Expenses / Income6.54M-1.61M-13.47M520.00K-308.00K
Before Tax Income-29.14M-33.74M-27.26M-8.72M-8.32M
Income Tax Expenses16.00K20.00K7.00K158.00K146.00K
Net Income-29.16M-33.76M-27.27M-8.88M-8.46M
Interest Expenses39.00K1.77M13.27M217.00KN/A
Basic Shares Outstanding69.38M63.53M40.53M40.43M67.62M
Diluted Shares Outstanding69.38M63.53M40.53M40.43M67.62M
EBITDA-34.61M-32.14M-13.79M-9.06M-6.87M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-29.10M-31.97M-13.99M-8.51M-8.32M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙